2019-nCoV Vaccine mRNA-1273

mRNA vaccine against SARS-CoV-2, developed by Moderna.

Also Known As:

2019 nCoV Vaccine mRNA 1273; COVID 19 Vaccine Moderna; COVID-19 Vaccine, Moderna; CX 024414; CX024414; M 1273; M1273; Moderna COVID 19 Vaccine; Moderna COVID 19 Vaccine RNA; Moderna COVID 19 Vaccine, Bivalent; Moderna, COVID-19 Vaccine; TAK 919; TAK919; Vaccine, Moderna COVID-19; mRNA 1273; mRNA 1273.211; mRNA-1273, 2019-nCoV Vaccine; COVID-19 Vaccine Moderna; CX-024414; Elasomeran; M-1273; Moderna COVID-19 Vaccine; Moderna COVID-19 Vaccine RNA; Moderna COVID-19 Vaccine, Bivalent; Spikevax; TAK-919; mRNA-1273; mRNA-1273.211

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Recombinant Proteins: 2811
    - Synthetic Vaccines: 1084
      - Nucleic Acid-Based Vaccines: 116
        mRNA Vaccines: 3134
        2019-nCoV Vaccine mRNA-1273: 921
Complex Mixtures: 1947
- Biological Products
  - Vaccines: 128365
    - Synthetic Vaccines: 1084
      - Nucleic Acid-Based Vaccines: 116
        mRNA Vaccines: 3134
        2019-nCoV Vaccine mRNA-1273: 921
    - Viral Vaccines: 473
      - COVID-19 Vaccines: 8432
        2019-nCoV Vaccine mRNA-1273: 921
Biological Factors: 2560
- Antigens: 145631
  - Synthetic Vaccines: 1084
    - Nucleic Acid-Based Vaccines: 116
      - mRNA Vaccines: 3134
        2019-nCoV Vaccine mRNA-1273: 921

Swiss HIV Cohort Study and the Swiss Transplant Cohort Study Selected Research

Swiss HIV Cohort Study and the Swiss Transplant Cohort Study Research Topics

Disease

Drug/Important Bio-Agent (IBA)